We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+7.93%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$16.7B
AUM Growth
+$329M
Cap. Flow
-$710M
Cap. Flow %
-4.25%
Top 10 Hldgs %
19.03%
Holding
2,687
New
132
Increased
900
Reduced
1,002
Closed
108

Top Buys

Rank Stock Value
1
PGR icon
Progressive
PGR
+$232M
2
BNL icon
Broadstone Net Lease
BNL
+$66.5M
3
APH icon
Amphenol
APH
+$64M
4
SNPS icon
Synopsys
SNPS
+$46.8M
5
XLNX
Xilinx Inc
XLNX
+$46.5M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$78M
2
KEYS icon
Keysight
KEYS
+$69.7M
3
ADP icon
Automatic Data Processing
ADP
+$68.4M
4
CSCO icon
Cisco
CSCO
+$60.5M
5
OMC icon
Omnicom Group
OMC
+$52.8M

Sector Composition

Rank Sector Weight
1 Technology 23.23%
2 Healthcare 13.49%
3 Financials 11.88%
4 Consumer Discretionary 9.14%
5 Industrials 8.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WIW
1701
Western Asset Inflation-Linked Opportunities & Income Fund
WIW
$505M
$16K ﹤0.01%
1,500
WNC icon
1702
Wabash National
WNC
$512M
$16K ﹤0.01%
1,345
-27
-2% -$317
WSBC icon
1703
WesBanco
WSBC
$3.97B
$16K ﹤0.01%
784
CPAY icon
1704
Corpay
CPAY
$25B
$16K ﹤0.01%
70
+16
+30% +$3.95K
CTLT
1705
DELISTED
CATALENT, INC.
CTLT
$16K ﹤0.01%
197
+49
+33% +$4.14K
CSII
1706
DELISTED
Cardiovascular Systems, Inc.
CSII
$16K ﹤0.01%
419
+23
+6% +$743
AMCR icon
1707
Amcor
AMCR
$20.8B
$15K ﹤0.01%
289
+28
+11% +$1.52K
ANGO icon
1708
AngioDynamics
ANGO
$611M
$15K ﹤0.01%
1,256
+65
+5% +$617
BHF icon
1709
Brighthouse Financial
BHF
$3.56B
$15K ﹤0.01%
580
-241
-29% -$7K
BIO icon
1710
Bio-Rad Laboratories Class A
BIO
$8.71B
$15K ﹤0.01%
32
+5
+19% +$2.53K
CORT icon
1711
Corcept Therapeutics
CORT
$12.4B
$15K ﹤0.01%
904
+36
+4% +$574
CZA icon
1712
Invesco Zacks Mid-Cap ETF
CZA
$190M
$15K ﹤0.01%
233
DBRG icon
1713
DigitalBridge
DBRG
$2.93B
$15K ﹤0.01%
1,438
-66
-4% -$639
FLEX icon
1714
Flex
FLEX
$41.7B
$15K ﹤0.01%
1,787
GFI icon
1715
Gold Fields
GFI
$29B
$15K ﹤0.01%
1,257
-467
-27% -$5.74K
RRC icon
1716
Range Resources
RRC
$9.38B
$15K ﹤0.01%
2,279
+38
+2% +$275
TIMB icon
1717
TIM SA
TIMB
$9.16B
$15K ﹤0.01%
1,336
-76
-5% -$1.04K
TRUP icon
1718
Trupanion
TRUP
$1.07B
$15K ﹤0.01%
+192
New +$11.5K
USPH icon
1719
US Physical Therapy
USPH
$1.2B
$15K ﹤0.01%
176
+8
+5% +$688
VICR icon
1720
Vicor
VICR
$9.56B
$15K ﹤0.01%
193
+7
+4% +$557
XHR
1721
Xenia Hotels & Resorts
XHR
$1.9B
$15K ﹤0.01%
1,762
+331
+23% +$2.92K
PACW
1722
DELISTED
PacWest Bancorp
PACW
$15K ﹤0.01%
912
-67
-7% -$1.24K
SCU
1723
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
$15K ﹤0.01%
1,294
SAL
1724
DELISTED
Salisbury Bancorp, Inc.
SAL
$15K ﹤0.01%
1,000
ENIA
1725
DELISTED
Enel Amricas S.A. American Depositary Shares (Each representing 50 shares of Common Stock)
ENIA
$15K ﹤0.01%
2,422

Similar funds

Glenmede Trust's Q3 2020 Portfolio in Review

As of Q3 2020, Glenmede Trust held 2,687 positions worth $16.7B, up 2% from $16.4B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Glenmede Trust withdrew a net $710M in Q3 2020, closing 108 positions and reducing 1,002 holdings. Its most notable exit was IBERIABANK Corp, an estimated $18.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Glenmede Trust opened a new position in Broadstone Net Lease worth $67.3M.

  • Glenmede Trust's largest Q3 2020 buy was Broadstone Net Lease: 4,009,897 shares worth $67.3M.
  • Glenmede Trust added most to Progressive in Q3 2020, an estimated $232M increase.
  • Glenmede Trust's biggest Q3 2020 reduction was Apple, cutting an estimated $78M.
  • Glenmede Trust fully exited IBERIABANK Corp in Q3 2020, selling an estimated $18.1M.
  • Glenmede Trust's ten largest holdings make up 19% of its $16.7B portfolio in Q3 2020.
  • Glenmede Trust opened 132 new positions and closed 108 in Q3 2020.
  • Glenmede Trust's portfolio value rose 2% quarter-over-quarter to $16.7B.

Based on Glenmede Trust's 13F filing for Q3 2020, filed 16 Nov 2020.